No black box warning on record for Pegasys

As of the latest FDA labeling reviewed, Pegasys (PEGINTERFERON ALFA-2A) does not carry a black box warning. Standard warnings and precautions still apply — see the full Pegasys medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Refer to the prescribing information of the other HCV antiviral drugs, including ribavirin, for their Warnings and Precautions. Use with ribavirin Birth defects and fetal death: patients must have a negative pregnancy test prior to therapy, use 2 forms of effective contraception, and have monthly pregnancy tests ( 5.1 ) PEGASYS Clinically Significant Adverse Reactions or

No black box warning on record for Pegasys

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Refer to the prescribing information of the other HCV antiviral drugs, including ribavirin, for their Warnings and Precautions. Use with ribavirin Birth defects and fetal death: patients must have a negative pregnancy test prior to therapy, use 2 forms of effective contraception, and have monthly pregnancy tests ( 5.1 ) PEGASYS Clinically Significant Adverse Reactions or

Pegasys Black Box Warning

No black box warning on record for Pegasys

Other warnings & precautions

Pegasys Black Box Warning

No black box warning on record for Pegasys

Other warnings & precautions